Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor Gene

Clinical trial NCT00588445 · COMPLETED

Trial details

NCT number: NCT00588445
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Non-small Cell Lung Cancer Bronchioloalveolar Cancer

Start date: 2004-06-01
Primary completion: 2010-09-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.